MAILIN QUINONES JIMENEZ: Open Payments
NPI 1013622836 · CARLSBAD, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 12 payments from 8 companies in 2025. Trend: 2023 $84 · 2024 $301 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| ARGENX US, INC. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
Products named: VALTOCO, UBRELVY, KESIMPTA, ULTOMIRIS, INGREZZA, VYVGART HYTRULO, REXULTI, CREXONT.
Industry payments across NM — which companies pay providers there.
